Literature DB >> 24504531

S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum.

Johann Steiner1, Andrea Schmitt, Matthias L Schroeter, Bernhard Bogerts, Peter Falkai, Christoph W Turck, Daniel Martins-de-Souza.   

Abstract

Here we report the downregulation of S100B in the nuclear proteome of the corpus callosum from nine schizophrenia patients compared to seven mentally healthy controls. Our data have been obtained primarily by mass spectrometry and later confirmed by Western blot. This is an intriguing finding coming from a brain region which is essentially composed by white matter, considering the potential role of S100B in the control of oligodendrocyte maturation. This data reinforce the importance of oligodendrocytes in schizophrenia, shedding more light to its pathobiology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24504531     DOI: 10.1007/s00406-014-0490-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  22 in total

1.  Elevated S100B levels in schizophrenia are associated with insulin resistance.

Authors:  J Steiner; M Walter; P Guest; A M Myint; K Schiltz; B Panteli; M Brauner; H-G Bernstein; T Gos; M Herberth; M L Schroeter; M J Schwarz; S Westphal; S Bahn; B Bogerts
Journal:  Mol Psychiatry       Date:  2010-01       Impact factor: 15.992

Review 2.  Schizophrenia, neurodevelopment and corpus callosum.

Authors:  G M Innocenti; F Ansermet; J Parnas
Journal:  Mol Psychiatry       Date:  2003-03       Impact factor: 15.992

3.  SNPs and haplotypes in the S100B gene reveal association with schizophrenia.

Authors:  Jixia Liu; Yongyong Shi; Junxia Tang; Tingwei Guo; Xiuxia Li; Yifeng Yang; Qingying Chen; Xinzhi Zhao; Guang He; Guoyin Feng; Niufan Gu; Shaomin Zhu; Huijun Liu; Lin He
Journal:  Biochem Biophys Res Commun       Date:  2005-03-04       Impact factor: 3.575

4.  Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation.

Authors:  Jean Christophe Deloulme; Eric Raponi; Benoît Jean Gentil; Nathalie Bertacchi; Alexander Marks; Gérard Labourdette; Jacques Baudier
Journal:  Mol Cell Neurosci       Date:  2004-12       Impact factor: 4.314

5.  Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels.

Authors:  Johann Steiner; Sabine Westphal; Matthias L Schroeter; Kolja Schiltz; Wolfgang Jordan; Ulf J Müller; Hans-Gert Bernstein; Bernhard Bogerts; Reinhold E Schmidt; Roland Jacobs
Journal:  Brain Behav Immun       Date:  2012-02-03       Impact factor: 7.217

Review 6.  S100B in schizophrenia: an update.

Authors:  Matthias Rothermundt; Jan Niklas Ahn; Silke Jörgens
Journal:  Gen Physiol Biophys       Date:  2009       Impact factor: 1.512

7.  S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study.

Authors:  Johann Steiner; Hans-Gert Bernstein; Hendrik Bielau; Nadine Farkas; Jana Winter; Henrik Dobrowolny; Ralf Brisch; Tomasz Gos; Christian Mawrin; Aye Mu Myint; Bernhard Bogerts
Journal:  J Psychiatr Res       Date:  2007-11-14       Impact factor: 4.791

8.  Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis.

Authors:  Matthias L Schroeter; Hashim Abdul-Khaliq; Michael Krebs; Albert Diefenbacher; Ingolf E Blasig
Journal:  Psychiatry Res       Date:  2009-04-16       Impact factor: 3.222

Review 9.  Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy.

Authors:  Hans-Gert Bernstein; Johann Steiner; Bernhard Bogerts
Journal:  Expert Rev Neurother       Date:  2009-07       Impact factor: 4.618

10.  Evidence for a wide extra-astrocytic distribution of S100B in human brain.

Authors:  Johann Steiner; Hans-Gert Bernstein; Hendrik Bielau; Annika Berndt; Ralf Brisch; Christian Mawrin; Gerburg Keilhoff; Bernhard Bogerts
Journal:  BMC Neurosci       Date:  2007-01-02       Impact factor: 3.288

View more
  10 in total

1.  The neuropathology of schizophrenia: new insights from postmortem studies.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06       Impact factor: 5.270

Review 2.  Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.

Authors:  Manveen K Sethi; Joseph Zaia
Journal:  Anal Bioanal Chem       Date:  2016-09-06       Impact factor: 4.142

Review 3.  White matter damage after traumatic brain injury: A role for damage associated molecular patterns.

Authors:  Molly Braun; Kumar Vaibhav; Nancy M Saad; Sumbul Fatima; John R Vender; Babak Baban; Md Nasrul Hoda; Krishnan M Dhandapani
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-19       Impact factor: 5.187

Review 4.  Schizophrenia and Alarmins.

Authors:  Huan Ma; Ning Cheng; Caiyi Zhang
Journal:  Medicina (Kaunas)       Date:  2022-05-24       Impact factor: 2.948

Review 5.  Psychiatric disorders biochemical pathways unraveled by human brain proteomics.

Authors:  Verônica M Saia-Cereda; Juliana S Cassoli; Daniel Martins-de-Souza; Juliana M Nascimento
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-07-04       Impact factor: 5.270

6.  Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers.

Authors:  Wu Hong; Min Zhao; Haozhe Li; Fanglan Peng; Fan Wang; Ningning Li; Hui Xiang; Yousong Su; Yueqi Huang; Shengyu Zhang; Guoqin Zhao; Rubai Zhou; Ling Mao; Zhiguang Lin; Yiru Fang; Qinting Zhang; Bin Xie
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

Review 7.  Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review.

Authors:  M O Trépanier; K E Hopperton; R Mizrahi; N Mechawar; R P Bazinet
Journal:  Mol Psychiatry       Date:  2016-06-07       Impact factor: 15.992

Review 8.  Proteomics Research in Schizophrenia.

Authors:  Katarina Davalieva; Ivana Maleva Kostovska; Andrew J Dwork
Journal:  Front Cell Neurosci       Date:  2016-02-16       Impact factor: 5.505

9.  Ribosomal DNA transcription in the dorsal raphe nucleus is increased in residual but not in paranoid schizophrenia.

Authors:  Marta Krzyżanowska; Johann Steiner; Ralf Brisch; Christian Mawrin; Stefan Busse; Katharina Braun; Zbigniew Jankowski; Hans-Gert Bernstein; Bernhard Bogerts; Tomasz Gos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-05       Impact factor: 5.270

Review 10.  The proteome of schizophrenia.

Authors:  Juliana M Nascimento; Daniel Martins-de-Souza
Journal:  NPJ Schizophr       Date:  2015-03-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.